{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:20:28Z","timestamp":1792783228236,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Qidong-Fudan Innovative Institute of Medical Sciences","award":["KTB002"],"award-info":[{"award-number":["KTB002"]}],"id":[{"id":"https:\/\/ror.org\/04y75dx46","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["24YF2704900"],"award-info":[{"award-number":["24YF2704900"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82503858"],"award-info":[{"award-number":["82503858"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiol med"],"DOI":"10.1007\/s11547-026-02295-w","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:10:06Z","timestamp":1792008606000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A two-stage model combining clinical and delta-radiomics features for prognosis in high-grade gliomas after chemoradiotherapy: a retrospective study"],"prefix":"10.1007","author":[{"given":"Qiyuan","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyuan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxia","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiabing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daoying","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,14]]},"reference":[{"key":"2295_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-031-23705-8","volume":"1405","author":"LM Wang","year":"2023","unstructured":"Wang LM, Englander ZK, Miller ML, Bruce JN (2023) Malignant Glioma. Adv Exp Med Biol 1405:1\u201330. https:\/\/doi.org\/10.1007\/978-3-031-23705-8","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"2295_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10014-023-00474-5","volume":"41","author":"T Komori","year":"2024","unstructured":"Komori T (2024) Beyond the WHO 2021 classification of the tumors of the central nervous system: transitioning from the 5th edition to the next. Brain Tumor Pathol 41(1):1\u20133. https:\/\/doi.org\/10.1007\/s10014-023-00474-5","journal-title":"Brain Tumor Pathol"},{"issue":"4","key":"2295_CR3","doi-asserted-by":"publisher","first-page":"934","DOI":"10.3171\/2023.2.JNS222755","volume":"139","author":"S Sauvageot","year":"2023","unstructured":"Sauvageot S, Boetto J, Duffau H (2023) Surgical, functional, and oncological considerations regarding awake resection for giant diffuse lower-grade glioma of more than 100 cm3. J Neurosurg 139(4):934\u2013943. https:\/\/doi.org\/10.3171\/2023.2.JNS222755","journal-title":"J Neurosurg"},{"issue":"5","key":"2295_CR4","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","volume":"10","author":"R Stupp","year":"2009","unstructured":"Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJB, Janzer RC et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10(5):459\u2013466. https:\/\/doi.org\/10.1016\/S1470-2045(09)70025-7","journal-title":"Lancet Oncol"},{"key":"2295_CR5","doi-asserted-by":"publisher","first-page":"109663","DOI":"10.1016\/j.radonc.2023.109663","volume":"184","author":"M Niyazi","year":"2023","unstructured":"Niyazi M, Andratschke N, Bendszus M et al (2023) ESTRO-EANO guideline on target delineation and radiotherapy details for glioblastoma. Radiother Oncol 184:109663. https:\/\/doi.org\/10.1016\/j.radonc.2023.109663","journal-title":"Radiother Oncol"},{"issue":"3","key":"2295_CR6","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/acn3.52306","volume":"12","author":"Z Wang","year":"2025","unstructured":"Wang Z, Wang L, Wang Y (2025) Radiomics in glioma: emerging trends and challenges. Ann Clin Transl Neurol 12(3):460\u2013477. https:\/\/doi.org\/10.1002\/acn3.52306","journal-title":"Ann Clin Transl Neurol"},{"key":"2295_CR7","doi-asserted-by":"publisher","first-page":"112412","DOI":"10.1016\/j.ejrad.2025.112412","volume":"193","author":"S Bijlsma","year":"2025","unstructured":"Bijlsma S, Maal T, Rubbert C et al (2025) AI radiomics predicts spatial glioma recurrence on preoperative MRI: a systematic review. Eur J Radiol 193:112412. https:\/\/doi.org\/10.1016\/j.ejrad.2025.112412","journal-title":"Eur J Radiol"},{"issue":"5","key":"2295_CR8","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1007\/s00330-023-10378-9","volume":"34","author":"G Wu","year":"2024","unstructured":"Wu G, Shi Z, Li Z, Xie X, Tang Q, Zhu J et al (2024) Study of radiochemotherapy decision-making for young high-risk low-grade glioma patients using a macroscopic and microscopic combined radiomics model. Eur Radiol 34(5):2861\u20132872. https:\/\/doi.org\/10.1007\/s00330-023-10378-9","journal-title":"Eur Radiol"},{"issue":"9","key":"2295_CR9","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.3174\/ajnr.A9296","volume":"47","author":"DA Yahav","year":"2026","unstructured":"Yahav-Dovrat A, Namdar K, Wagner MW et al (2026) Multiclass radiomics-based prediction of BRAF mutation status in pediatric low-grade gliomas using multisequence MRI. AJNR Am J Neuroradiol 47(9):2408\u20132415. https:\/\/doi.org\/10.3174\/ajnr.A9296","journal-title":"AJNR Am J Neuroradiol"},{"key":"2295_CR10","doi-asserted-by":"publisher","first-page":"112508","DOI":"10.1016\/j.ejrad.2025.112508","volume":"194","author":"J Li","year":"2026","unstructured":"Li J, Xu Q, Fan X et al (2026) Multi-sequence MRI radiomics model for discrimination of recurrence and pseudoprogression in gliomas. Eur J Radiol 194:112508. https:\/\/doi.org\/10.1016\/j.ejrad.2025.112508","journal-title":"Eur J Radiol"},{"key":"2295_CR11","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1186\/s12967-026-07971-z","volume":"24","author":"T Zhang","year":"2026","unstructured":"Zhang T, Zhu H, Sun H et al (2026) Radiomics in glioblastoma recurrence: advances in prediction, localization, and differentiation from treatment-related effects. J Transl Med 24:516. https:\/\/doi.org\/10.1186\/s12967-026-07971-z","journal-title":"J Transl Med"},{"issue":"1","key":"2295_CR12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s40001-025-02339-3","volume":"30","author":"WA Awuah","year":"2025","unstructured":"Awuah WA, Ben-Jaafar A, Roy S et al (2025) Predicting survival in malignant glioma using artificial intelligence. Eur J Med Res 30(1):61. https:\/\/doi.org\/10.1186\/s40001-025-02339-3","journal-title":"Eur J Med Res"},{"issue":"8","key":"2295_CR13","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s11547-024-01853-4","volume":"129","author":"V Nardone","year":"2024","unstructured":"Nardone V, Reginelli A, Rubini D, Gagliardi F, Del Tufo S, Belfiore MP et al (2024) Delta radiomics: an updated systematic review. Radiol Med 129(8):1197\u20131214. https:\/\/doi.org\/10.1007\/s11547-024-01853-4","journal-title":"Radiol Med"},{"issue":"12","key":"2295_CR14","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1007\/s11547-021-01436-7","volume":"126","author":"V Nardone","year":"2021","unstructured":"Nardone V, Reginelli A, Grassi R, Boldrini L, Vacca G, D\u2019Ippolito E et al (2021) Delta radiomics: a systematic review. Radiol Med 126(12):1571\u20131583. https:\/\/doi.org\/10.1007\/s11547-021-01436-7","journal-title":"Radiol Med"},{"key":"2295_CR15","doi-asserted-by":"publisher","first-page":"106987","DOI":"10.1016\/j.oraloncology.2024.106987","volume":"157","author":"GS Pan","year":"2024","unstructured":"Pan GS, Sun XM, Kong FF, Wang JZ, He XY, Lu XG et al (2024) Delta magnetic resonance imaging radiomics features-based nomogram predicts long-term efficacy after induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma. Oral Oncol 157:106987","journal-title":"Oral Oncol"},{"issue":"1","key":"2295_CR16","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12885-025-13509-1","volume":"25","author":"KS Wagner-Larsen","year":"2025","unstructured":"Wagner-Larsen KS, Lura N, Gulati A, Ryste S, Hodneland E, Fasmer KE et al (2025) MRI delta radiomics during chemoradiotherapy for prognostication in locally advanced cervical cancer. BMC Cancer 25(1):122. https:\/\/doi.org\/10.1186\/s12885-025-13509-1","journal-title":"BMC Cancer"},{"issue":"3","key":"2295_CR17","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s11060-026-05457-y","volume":"176","author":"E B\u0131y\u0131kl\u0131","year":"2026","unstructured":"B\u0131y\u0131kl\u0131 E, Aybal T, Aslan B et al (2026) Prognostic role of delta radiomics in pediatric pontine diffuse midline gliomas. J Neurooncol 176(3):206. https:\/\/doi.org\/10.1007\/s11060-026-05457-y","journal-title":"J Neurooncol"},{"issue":"4","key":"2295_CR18","doi-asserted-by":"publisher","first-page":"815","DOI":"10.3390\/biomedicines13040815","volume":"13","author":"MS Alshuhri","year":"2025","unstructured":"Alshuhri MS, Al-Mubarak HF, Qaisi A, Alhulail AA, AlMansour AGM, Madkhali Y et al (2025) MRI delta radiomics to track early changes in tumor following radiation: application in glioblastoma mouse model. Biomedicines 13(4):815. https:\/\/doi.org\/10.3390\/biomedicines13040815","journal-title":"Biomedicines"},{"key":"2295_CR19","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/978-1-4614-7657-3_19","volume-title":"Intra-operative imaging and image-guided therapy","author":"R Kikinis","year":"2014","unstructured":"Kikinis R, Pieper SD, Vosburgh KG (2014) 3D Slicer: a platform for subject-specific image analysis, visualization, and clinical support. In: Jolesz FA (ed) Intra-operative imaging and image-guided therapy. Springer, New York, pp 277\u2013289. https:\/\/doi.org\/10.1007\/978-1-4614-7657-3_19"},{"issue":"21","key":"2295_CR20","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","volume":"77","author":"J van Griethuysen","year":"2017","unstructured":"van Griethuysen J, Fedorov A, Parmar C, Hosny A, Aucoin N, Narayan V et al (2017) Computational radiomics system to decode the radiographic phenotype. Cancer Res 77(21):e104\u2013e107. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-0339","journal-title":"Cancer Res"},{"issue":"5","key":"2295_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v039.i05","volume":"39","author":"N Simon","year":"2011","unstructured":"Simon N, Friedman JH, Hastie T, Tibshirani R (2011) Regularization paths for Cox\u2019s proportional hazards model via coordinate descent. J Stat Softw 39(5):1\u201313","journal-title":"J Stat Softw"},{"key":"2295_CR22","first-page":"1","volume-title":"Random survival forests","author":"H Ishwaran","year":"2019","unstructured":"Ishwaran H, Lu M (2019) Random survival forests. Wiley, pp 1\u201313"},{"issue":"1","key":"2295_CR23","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12874-018-0482-1","volume":"18","author":"JL Katzman","year":"2018","unstructured":"Katzman JL, Shaham U, Cloninger A, Bates J, Jiang T, Kluger Y (2018) Deepsurv: personalized treatment recommender system using a Cox proportional hazards deep neural network. BMC Med Res Methodol 18(1):24. https:\/\/doi.org\/10.1186\/s12874-018-0482-1","journal-title":"BMC Med Res Methodol"},{"key":"2295_CR24","doi-asserted-by":"publisher","first-page":"111180","DOI":"10.1016\/j.radonc.2025.111180","volume":"213","author":"Y Li","year":"2025","unstructured":"Li Y, Jiang Z, Tan J et al (2025) An intelligent postoperative management system for glioblastoma integrating automated segmentation, risk stratification, and recurrence spatial mapping. Radiother Oncol 213:111180. https:\/\/doi.org\/10.1016\/j.radonc.2025.111180","journal-title":"Radiother Oncol"},{"key":"2295_CR25","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6560\/ae11f5","author":"M Pan","year":"2025","unstructured":"Pan M, Duan H, Ni C, Han L, Yu J, Wang Y (2025) Evaluation of radiosensitivity for high grade gliomas patients using a multi-temporal graph convolutional networks. Phys Med Biol. https:\/\/doi.org\/10.1088\/1361-6560\/ae11f5","journal-title":"Phys Med Biol"},{"issue":"1","key":"2295_CR26","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1186\/s40001-025-03333-5","volume":"30","author":"A Mahmoudi","year":"2025","unstructured":"Mahmoudi A, Sadeghi AZ, Iraji H, Barahman M, Yazdani E, Mahdavi SR (2025) Correlation of contrast-enhancing tumor region on pre-radiotherapy MRI with overall survival in glioblastoma. Eur J Med Res 30(1):1121. https:\/\/doi.org\/10.1186\/s40001-025-03333-5","journal-title":"Eur J Med Res"},{"issue":"18","key":"2295_CR27","doi-asserted-by":"publisher","first-page":"4636","DOI":"10.3390\/cancers15184636","volume":"15","author":"W Farzana","year":"2023","unstructured":"Farzana W, Basree MM, Diawara N, Shboul ZA, Dubey S, Lockhart MM et al (2023) Prediction of rapid early progression and survival risk with pre-radiation MRI in WHO grade 4 glioma patients. Cancers (Basel) 15(18):4636. https:\/\/doi.org\/10.3390\/cancers15184636","journal-title":"Cancers (Basel)"},{"issue":"5","key":"2295_CR28","doi-asserted-by":"publisher","first-page":"3040","DOI":"10.3390\/ijms25053040","volume":"25","author":"Z Lan","year":"2024","unstructured":"Lan Z, Li X, Zhang X (2024) Glioblastoma: an update in pathology, molecular mechanisms and biomarkers. Int J Mol Sci 25(5):3040. https:\/\/doi.org\/10.3390\/ijms25053040","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2295_CR29","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s40478-025-02044-6","volume":"13","author":"A Tauzi\u00e8de-Espariat","year":"2025","unstructured":"Tauzi\u00e8de-Espariat A, Roux A, Benzakoun J, Kauv P, Tazi S, M\u00e9tais A, Suwala AK, Hinz F, Hasty L, Filser M, Masliah-Planchon J, Saffroy R, Bucau M, Pallud J, Varlet P (2025) ATRX loss in adult gliomas lacking H3 alterations or IDH mutations, an exceptional situation for exceptional diagnoses: the experience of Sainte-Anne hospital. Acta Neuropathol Commun 13(1):131. https:\/\/doi.org\/10.1186\/s40478-025-02044-6","journal-title":"Acta Neuropathol Commun"},{"issue":"7","key":"2295_CR30","doi-asserted-by":"publisher","first-page":"4576","DOI":"10.1097\/JS9.0000000000002488","volume":"111","author":"J Liu","year":"2025","unstructured":"Liu J, Jiang S, Wu Y, Zou R, Bao Y, Wang N, Tu J, Xiong J, Liu Y, Li Y (2025) Deep learning-based radiomics and machine learning for prognostic assessment in IDH-wildtype glioblastoma after maximal safe surgical resection: a multicenter study. Int J Surg 111(7):4576\u20134585. https:\/\/doi.org\/10.1097\/JS9.0000000000002488","journal-title":"Int J Surg"},{"issue":"1","key":"2295_CR31","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s10143-025-03419-y","volume":"48","author":"I Mohammadzadeh","year":"2025","unstructured":"Mohammadzadeh I, Hajikarimloo B, Niroomand B, Eini P, Ghanbarnia R, Habibi MA, Albakr A, Borghei-Razavi H (2025) Application of artificial intelligence in forecasting survival in high-grade glioma: systematic review and meta-analysis involving 79,638 participants. Neurosurg Rev 48(1):240. https:\/\/doi.org\/10.1007\/s10143-025-03419-y","journal-title":"Neurosurg Rev"},{"issue":"12","key":"2295_CR32","doi-asserted-by":"publisher","first-page":"e0226348","DOI":"10.1371\/journal.pone.0226348","volume":"14","author":"Y Chang","year":"2019","unstructured":"Chang Y, Lafata K, Sun W, Wang C, Chang Z, Kirkpatrick JP, Yin FF (2019) An investigation of machine learning methods in delta-radiomics feature analysis. PLoS ONE 14(12):e0226348. https:\/\/doi.org\/10.1371\/journal.pone.0226348","journal-title":"PLoS ONE"},{"issue":"30","key":"2295_CR33","doi-asserted-by":"publisher","first-page":"eadw8330","DOI":"10.1126\/sciadv.adw8330","volume":"11","author":"C Huang","year":"2025","unstructured":"Huang C, Xin X, Hao X, Zhou S, Xie Z, He L et al (2025) Construction of a whole-brain panorama for glioma vasculature reveals tumor heterogeneity and blood-brain barrier disruption. Sci Adv 11(30):eadw8330. https:\/\/doi.org\/10.1126\/sciadv.adw8330","journal-title":"Sci Adv"},{"key":"2295_CR34","unstructured":"Kanderi T, Munakomi S, Gupta V (2025) Glioblastoma multiforme. In: StatPearls. Treasure Island (FL): StatPearls Publishing; http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK558954\/."},{"issue":"1","key":"2295_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11060-025-05053-6","volume":"174","author":"AS Marwaha","year":"2025","unstructured":"Marwaha AS, Shepard MJ, Karlovits SM, Herbst J, Wegner RE (2025) Advancements in adaptive MR-guided radiotherapy for high-grade gliomas. J Neurooncol 174(1):1\u20136. https:\/\/doi.org\/10.1007\/s11060-025-05053-6","journal-title":"J Neurooncol"},{"key":"2295_CR36","doi-asserted-by":"publisher","first-page":"109617","DOI":"10.1016\/j.radonc.2023.109617","volume":"183","author":"Y Kim","year":"2023","unstructured":"Kim Y, Kim KH, Park J, Yoon HI, Sung W (2023) Prognosis prediction for glioblastoma multiforme patients using machine learning approaches: development of the clinically applicable model. Radiother Oncol 183:109617. https:\/\/doi.org\/10.1016\/j.radonc.2023.109617","journal-title":"Radiother Oncol"},{"issue":"1","key":"2295_CR37","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12957-025-03760-y","volume":"23","author":"X Li","year":"2025","unstructured":"Li X, Song L, Zhang H, Ji X, Song P, Liu J et al (2025) Predicting postoperative recurrence and survival in glioma patients using enhanced MRI-based delta habitat radiomics: an 8-year retrospective pilot study. World J Surg Oncol 23(1):104","journal-title":"World J Surg Oncol"},{"issue":"1","key":"2295_CR38","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s11060-025-05037-6","volume":"174","author":"YC Yun","year":"2025","unstructured":"Yun YC, Jende JME, Garh\u00f6fer F, Wolf S, Holz K, Hohmann A, Vollmuth P, Bendszus M, Schlemmer HP, Sahm F, Heiland S, Wick W, Venkataramani V, Kurz FT (2025) Combined peritumoral radiomics and clinical features predict 12-month progression free survival in glioblastoma. J Neurooncol 174(1):111\u2013120. https:\/\/doi.org\/10.1007\/s11060-025-05037-6","journal-title":"J Neurooncol"}],"container-title":["La radiologia medica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-026-02295-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11547-026-02295-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-026-02295-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:10:08Z","timestamp":1792008608000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11547-026-02295-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,14]]},"references-count":38,"alternative-id":["2295"],"URL":"https:\/\/doi.org\/10.1007\/s11547-026-02295-w","relation":{},"ISSN":["1826-6983"],"issn-type":[{"value":"1826-6983","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,14]]},"assertion":[{"value":"10 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this dual\u2011center retrospective study was granted by the Institutional Review Board (IRB) of Huashan Hospital, Fudan University, under a reliance agreement covering both participating institutions and both study cohorts at Huashan Hospital and Shanghai Gamma Hospital, and the research was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was waived due to the study\u2019s retrospective nature.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}